2270. Initial Treatment Selection Among Patients with Recurrent Pseudomonas aeruginosa (PSA) Infections (Infxs): Does Prior PSA Antibiotic Susceptibility Results Effect Subsequent Empiric Treatment Decisions?

BACKGROUND: Resistance to commonly used anti-pseudomonal β-lactams (AP-BLs) like piperacillin/tazobactam (TZP), meropenem (MER) and cefepime (CEF) among patients (patients) with PSA infx is increasing. To minimize receipt of DAT among patients with PSA infxs, clinicians need to consider the patient’...

Descripción completa

Detalles Bibliográficos
Autores principales: Puzniak, Laura, Gupta, Vikas, Dillon, Ryan J, Yu, Kalvin, Murray, John, Lodise, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809578/
http://dx.doi.org/10.1093/ofid/ofz360.1948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809578/
http://dx.doi.org/10.1093/ofid/ofz360.1948

Ejemplares similares